Published in Clin Ther on July 01, 2005
Antihistamine effects on experimental middle ear inflammatory model. Eur Arch Otorhinolaryngol (2008) 0.91
H1 antihistamines: current status and future directions. World Allergy Organ J (2008) 0.87
A review of the evidence from comparative studies of levocetirizine and desloratadine for the symptoms of allergic rhinitis. Clin Ther (2006) 0.75
Oral bioavailability and pharmacokinetic study of cetrizine HCl in Iranian healthy volunteers. Res Pharm Sci (2009) 0.75
Efficacy and safety of rupatadine for allergic rhino-conjunctivitis: a systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis. Curr Med Res Opin (2013) 1.92
Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest (2007) 1.84
Why do doctors and patients not follow guidelines? Curr Opin Allergy Clin Immunol (2009) 1.35
Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language. J Allergy Clin Immunol (2013) 1.33
Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol (2006) 1.26
Quality of life in Duchenne muscular dystrophy: the subjective impact on children and parents. J Child Neurol (2011) 1.13
Possible role of climate changes in variations in pollen seasons and allergic sensitizations during 27 years. Ann Allergy Asthma Immunol (2010) 1.13
The link between allergic rhinitis and asthma: the united airways disease. Expert Rev Clin Immunol (2010) 1.11
Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. J Allergy Clin Immunol (2007) 1.11
The ImmunoCAP ISAC molecular allergology approach in adult multi-sensitized Italian patients with respiratory symptoms. Clin Biochem (2011) 1.08
Long-lasting effects of sublingual immunotherapy according to its duration: a 15-year prospective study. J Allergy Clin Immunol (2010) 1.06
Bridging allergologic and botanical knowledge in seasonal allergy: a role for phenology. Ann Allergy Asthma Immunol (2010) 1.04
Perturbations of natural killer cell regulatory functions in respiratory allergic diseases. J Allergy Clin Immunol (2007) 0.98
Clara cell 16 protein in COPD sputum: a marker of small airways damage? Respir Med (2007) 0.97
How adherent to sublingual immunotherapy prescriptions are patients? The manufacturers' viewpoint. J Allergy Clin Immunol (2010) 0.94
Specific immunotherapy for respiratory allergy: state of the art according to current meta-analyses. Ann Allergy Asthma Immunol (2009) 0.93
Allergic diseases and their impact on quality of life. Ann Allergy Asthma Immunol (2006) 0.92
Quantitative assessment of the adherence to sublingual immunotherapy. J Allergy Clin Immunol (2004) 0.90
Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha. Eur J Immunol (2002) 0.89
Allergen-specific immunotherapy in asthmatic children: from the basis to clinical applications. Expert Rev Vaccines (2013) 0.89
Asthma management failure: a flaw in physicians' behavior or in patients' knowledge? J Asthma (2011) 0.88
New insights into airway remodelling in asthma and its possible modulation. Curr Opin Allergy Clin Immunol (2008) 0.87
Disability in COPD and its relationship to clinical and patient-reported outcomes. Curr Med Res Opin (2011) 0.86
Economic evaluation of sublingual immunotherapy vs symptomatic treatment in adults with pollen-induced respiratory allergy: the Sublingual Immunotherapy Pollen Allergy Italy (SPAI) study. Ann Allergy Asthma Immunol (2006) 0.86
Asthma mortality, inhaled steroids, and changing asthma therapy in Argentina (1990-1999). Respir Med (2005) 0.86
Patient knowledge, perceptions, expectations and satisfaction on allergen-specific immunotherapy: a survey. Respir Med (2012) 0.86
Sublingual Immunotherapy: Clinical Indications in the WAO-SLIT Position Paper. World Allergy Organ J (2010) 0.85
Harmful effect of immunotherapy in children with combined snail and mite allergy. J Allergy Clin Immunol (2002) 0.84
A review of the use of fluticasone furoate since its launch. Expert Opin Pharmacother (2011) 0.84
Office spirometry can improve the diagnosis of obstructive airway disease in primary care setting. Respir Med (2009) 0.84
The clinical characteristics of respiratory allergy in immigrants in northern Italy. Int Arch Allergy Immunol (2008) 0.84
Pharmacokinetics of Der p 2 allergen and derived monomeric allergoid in allergic volunteers. Int Arch Allergy Immunol (2005) 0.84
Clinical and cytologic characteristics of allergic rhinitis in elderly patients. Ann Allergy Asthma Immunol (2012) 0.84
The possible influence of the environment on respiratory allergy: a survey on immigrants to Italy. Ann Allergy Asthma Immunol (2011) 0.83
Sublingual immunotherapy for allergic rhinitis and conjunctivitis. Immunotherapy (2013) 0.83
Clinical, functional, and immunologic effects of sublingual immunotherapy in birch pollinosis: a 3-year randomized controlled study. J Allergy Clin Immunol (2005) 0.83
Treatment of acquired cold urticaria with cetirizine and zafirlukast in combination. J Am Acad Dermatol (2003) 0.83
Patients with asthma and comorbid allergic rhinitis: is optimal quality of life achievable in real life? PLoS One (2012) 0.83
When allergic rhinitis is not only allergic. Am J Rhinol Allergy (2009) 0.82
Chronic obstructive pulmonary disease patient well-being and its relationship with clinical and patient-reported outcomes: a real-life observational study. Respiration (2011) 0.82
The relationship between asthma control and quality-of-life impairment due to chronic cough: a real-life study. Ann Allergy Asthma Immunol (2008) 0.82
Biomarker discovery in asthma and COPD by proteomic approaches. Proteomics Clin Appl (2014) 0.82
Allergy training and immunotherapy in Latin America: results of a regional overview. Ann Allergy Asthma Immunol (2013) 0.82
Serum cytotoxic T lymphocyte-associated antigen 4 in Hymenoptera venom allergy and its modulation by specific immunotherapy. J Allergy Clin Immunol (2008) 0.82
Airway remodelling in children: when does it start? Curr Opin Allergy Clin Immunol (2007) 0.81
Impact of bariatric surgery on pulmonary function and nitric oxide in asthmatic and non-asthmatic obese patients. J Asthma (2011) 0.81
Component-resolved diagnosis in pediatric allergic rhinoconjunctivitis and asthma. Curr Opin Allergy Clin Immunol (2013) 0.81
The safety of allergen specific sublingual immunotherapy. Curr Drug Saf (2007) 0.81
Molecular allergy diagnosis: we need to become more knowledgeable. Ann Allergy Asthma Immunol (2012) 0.81
Oral and sublingual immunotherapy in paediatric patients. Curr Opin Allergy Clin Immunol (2003) 0.80
Safety and tolerability of sublingual immunotherapy in clinical trials and real life. Curr Opin Allergy Clin Immunol (2013) 0.80
Focus on cat allergen (Fel d 1): immunological and aerodynamic characteristics, modality of airway sensitization and avoidance strategies. Int Arch Allergy Immunol (2003) 0.80
Cross-sectional comparison of the characteristics of respiratory allergy in immigrants and Italian children. Pediatr Allergy Immunol (2014) 0.80
Effects of fexofenadine and other antihistamines on components of the allergic response: adhesion molecules. J Allergy Clin Immunol (2003) 0.80
Obstructive lung diseases and inhaler treatment: results from a national public pragmatic survey. Respir Res (2013) 0.80
Emerging drugs for allergic conjunctivitis. Expert Opin Emerg Drugs (2014) 0.80
Frequency of acute systemic reactions in patients with allergic rhinitis and asthma treated with sublingual immunotherapy. Ann Allergy Asthma Immunol (2008) 0.80
Eosinophilic esophagitis: which role for food and inhalant allergens? Asia Pac Allergy (2012) 0.80
Non-injection routes for allergen immunotherapy: focus on sublingual immunotherapy. Inflamm Allergy Drug Targets (2006) 0.79
Sublingual immunotherapy: update 2006. Curr Opin Allergy Clin Immunol (2006) 0.79
Emerging sublingual immunotherapy drugs. Expert Opin Pharmacother (2010) 0.79
Development and validation of the Drug Hypersensitivity Quality of Life Questionnaire. Ann Allergy Asthma Immunol (2011) 0.79
Administration of a polyvalent mechanical bacterial lysate to elderly patients with COPD: Effects on circulating T, B and NK cells. Immunol Lett (2012) 0.79
Effects of different up-dosing regimens for hymenoptera venom immunotherapy on serum CTLA-4 and IL-10. PLoS One (2012) 0.78
Sublingual immunotherapy: other indications. Immunol Allergy Clin North Am (2011) 0.78
An update on the asthma-rhinitis link. Curr Opin Allergy Clin Immunol (2004) 0.78
May we strengthen the human natural defenses with bacterial lysates? World Allergy Organ J (2010) 0.78
The role of Pneumococcal vaccine. Pulm Pharmacol Ther (2008) 0.78
Advances in allergen-specific immunotherapy. Curr Drug Targets (2009) 0.78
Incidence and risk factors for subcutaneous immunotherapy anaphylaxis: the optimization of safety. Expert Rev Clin Immunol (2014) 0.78
Pitfalls in respiratory allergy management: alexithymia and its impact on patient-reported outcomes. J Asthma (2010) 0.78
Randomized open comparison of the safety of SLIT in a no-updosing and traditional updosing schedule in patients with Parietaria allergy. Allergol Immunopathol (Madr) (2006) 0.77
Disability in moderate chronic obstructive pulmonary disease: prevalence, burden and assessment - results from a real-life study. Respiration (2015) 0.77
Sublingual immunotherapy: where do we stand? Present and future. Curr Opin Allergy Clin Immunol (2009) 0.77
A model of allergen-driven human airway contraction: beta2 pathway dysfunction without cytokine involvement. Ann Allergy Asthma Immunol (2005) 0.77
Safety profile of sublingual immunotherapy. Treat Respir Med (2006) 0.77
Sublingual immunotherapy: an update. Curr Opin Allergy Clin Immunol (2004) 0.77
Efficacy and safety of sublingual immunotherapy. Ann Allergy Asthma Immunol (2004) 0.77
Coping with asthma: is the physician able to identify patient's behaviour? Respir Med (2012) 0.77
Levocetirizine in the treatment of allergic diseases. Expert Opin Pharmacother (2009) 0.77
Long-acting bronchodilators improve health related quality of life in patients with COPD. Respir Med (2013) 0.77
Sublingual immunotherapy for allergic respiratory diseases: efficacy and safety. Immunol Allergy Clin North Am (2011) 0.76
Specific immunotherapy with allergens: an important tool in the treatment of the allergic diseases. J Dtsch Dermatol Ges (2012) 0.76
Immunotherapy in polysensitized patients: new chances for the allergists? Ann Allergy Asthma Immunol (2012) 0.76
Medical treatment reverses cytokine pattern in allergic and nonallergic chronic rhinosinusitis in asthmatic children. Pediatr Allergy Immunol (2003) 0.76
Comparison of the effects in the nose and skin of a single dose of desloratadine and levocetirizine over 24 hours. Int Arch Allergy Immunol (2004) 0.76
Long-term comparison of sublingual immunotherapy vs inhaled budesonide in patients with mild persistent asthma due to grass pollen. Ann Allergy Asthma Immunol (2009) 0.76
A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma. Int Arch Allergy Immunol (2016) 0.76
Will sublingual immunotherapy offer benefit for asthma? Curr Allergy Asthma Rep (2013) 0.76
Pharmacotherapy of allergic rhinitis: current options and future perspectives. Expert Opin Pharmacother (2013) 0.76
Sublingual immunotherapy for Alternaria-induced allergic rhinitis: a randomized placebo-controlled trial. Ann Allergy Asthma Immunol (2010) 0.75
DRACMA one year after: which changes have occurred in diagnosis and treatment of CMA in Italy? Ital J Pediatr (2011) 0.75
Targeted therapy for allergic asthma: predicting and evaluating response to omalizumab. Expert Rev Clin Immunol (2007) 0.75
Is health-related quality of life associated with upper and lower airway inflammation in asthmatics? Biomed Res Int (2013) 0.75
Latex immunotherapy: state of the art. Ann Allergy Asthma Immunol (2012) 0.75
Disease-modifying effect and economic implications of sublingual immunotherapy. J Allergy Clin Immunol (2010) 0.75
New insights in sublingual immunotherapy. Curr Allergy Asthma Rep (2006) 0.75
Local nasal specific immunotherapy for allergic rhinitis. Allergy Asthma Clin Immunol (2006) 0.75
Molecular diagnosis and precision medicine in allergy management. Clin Chem Lab Med (2016) 0.75